GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaTher Holdings Ltd (XCNQ:PHRM) » Definitions » Scaled Net Operating Assets

PharmaTher Holdings (XCNQ:PHRM) Scaled Net Operating Assets : 0.02 (As of Feb. 2024)


View and export this data going back to 2021. Start your Free Trial

What is PharmaTher Holdings Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

PharmaTher Holdings's operating assets for the quarter that ended in Feb. 2024 was C$0.32 Mil. PharmaTher Holdings's operating liabilities for the quarter that ended in Feb. 2024 was C$0.25 Mil. PharmaTher Holdings's Total Assets for the quarter that ended in Nov. 2023 was C$3.57 Mil. Therefore, PharmaTher Holdings's scaled net operating assets (SNOA) for the quarter that ended in Feb. 2024 was 0.02.


PharmaTher Holdings Scaled Net Operating Assets Historical Data

The historical data trend for PharmaTher Holdings's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaTher Holdings Scaled Net Operating Assets Chart

PharmaTher Holdings Annual Data
Trend May21 May22 May23
Scaled Net Operating Assets
-0.05 -0.05 -0.07

PharmaTher Holdings Quarterly Data
Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.06 -0.11 -0.08 -0.06 0.02

Competitive Comparison of PharmaTher Holdings's Scaled Net Operating Assets

For the Biotechnology subindustry, PharmaTher Holdings's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmaTher Holdings's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PharmaTher Holdings's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where PharmaTher Holdings's Scaled Net Operating Assets falls into.



PharmaTher Holdings Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

PharmaTher Holdings's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in May. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: May. 2023 )
=(Operating Assets (A: May. 2023 )-Operating Liabilities (A: May. 2023 ))/Total Assets (A: May. 2022 )
=(0.056999999999999-0.892)/12.164
=-0.07

where

Operating Assets(A: May. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=6.31 - 6.253
=0.056999999999999

Operating Liabilities(A: May. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=0.892 - 0 - 0
=0.892

PharmaTher Holdings's Scaled Net Operating Assets (SNOA) for the quarter that ended in Feb. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Feb. 2024 )
=(Operating Assets (Q: Feb. 2024 )-Operating Liabilities (Q: Feb. 2024 ))/Total Assets (Q: Nov. 2023 )
=(0.318-0.252)/3.571
=0.02

where

Operating Assets(Q: Feb. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=2.914 - 2.596
=0.318

Operating Liabilities(Q: Feb. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=0.252 - 0 - 0
=0.252

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PharmaTher Holdings Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of PharmaTher Holdings's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaTher Holdings (XCNQ:PHRM) Business Description

Traded in Other Exchanges
Address
82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
PharmaTher Holdings Ltd is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals for FDA approval to treat mental health, neurological, and pain disorders. Its product pipeline includes Ketamine, KETABET, Microneedle Patch among others.
Executives
Fabio Chianelli Director, Senior Officer

PharmaTher Holdings (XCNQ:PHRM) Headlines

No Headlines